Literature DB >> 16102605

Role of apoptosis and cytokines in influenza virus morbidity.

Edward W A Brydon1, Susan J Morris, Clive Sweet.   

Abstract

Influenza virus is a major human pathogen that causes epidemics and pandemics with increased morbidity and, especially in the elderly and those with pre-existing medical conditions, increased mortality. Influenza is characterised by respiratory symptoms and constitutional symptoms. Whilst knowledge of the mechanisms underlying host and tissue specificity has advanced considerably of late we still know relatively little about other aspects of influenza virus virulence. In this review, we will explore what is known about the role of apoptosis in respiratory epithelial cell damage and the role of cytokines in inflammation and constitutional symptoms with particular emphasis on the link between apoptosis, inflammation, fever and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16102605     DOI: 10.1016/j.femsre.2004.12.003

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  62 in total

1.  Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication.

Authors:  Jeffrey E McLean; Emmanuel Datan; Demetrius Matassov; Zahra F Zakeri
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

2.  Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells.

Authors:  Emily A Desmet; Joseph A Hollenbaugh; Patricia J Sime; Terry W Wright; David J Topham; Andrea J Sant; Toru Takimoto; Stephen Dewhurst; Sanjay B Maggirwar
Journal:  Virology       Date:  2010-02-25       Impact factor: 3.616

3.  Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection.

Authors:  Eric Ka-Wai Hui; Donald F Smee; Min-Hui Wong; Debi P Nayak
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response.

Authors:  Jiao Hu; Yiqun Mo; Xiaoquan Wang; Min Gu; Zenglei Hu; Lei Zhong; Qiwen Wu; Xiaoli Hao; Shunlin Hu; Wenbo Liu; Huimou Liu; Xiaowen Liu; Xiufan Liu
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

5.  Cytokine and chemokine responses of lung exposed to surrogate viral and bacterial infections.

Authors:  Teresa A Liberati; Rita A Trammell; Michelle Randle; Sarah Barrett; Linda A Toth
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells.

Authors:  Mayo Ueda; Tomo Daidoji; Anariwa Du; Cheng-Song Yang; Madiha S Ibrahim; Kazuyoshi Ikuta; Takaaki Nakaya
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

7.  Analysis of host- and strain-dependent cell death responses during infectious salmon anemia virus infection in vitro.

Authors:  Berit L Schiøtz; Espen S Baekkevold; Lene C Poulsen; Siri Mjaaland; Tor Gjøen
Journal:  Virol J       Date:  2009-07-01       Impact factor: 4.099

8.  Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells.

Authors:  Shannon R Matzinger; Timothy D Carroll; Joseph C Dutra; Zhong-Min Ma; Christopher J Miller
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis.

Authors:  Gallen B Triana-Baltzer; Maria Babizki; Michael C W Chan; Adam C N Wong; Laura M Aschenbrenner; Erin R Campbell; Qi-Xiang Li; Renee W Y Chan; J S Malik Peiris; John M Nicholls; Fang Fang
Journal:  J Antimicrob Chemother       Date:  2009-11-26       Impact factor: 5.790

Review 10.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.